🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/03/2016 | 64,50 | 65,01 | 62,89 | 63,96 | +0,01% | 3,29% | 429.123 |
| 24/03/2016 | 62,61 | 64,85 | 61,52 | 63,95 | +1,32% | 5,33% | 569.225 |
| 23/03/2016 | 64,62 | 65,68 | 62,88 | 63,11 | -2,98% | 4,33% | 593.591 |
| 22/03/2016 | 62,20 | 65,21 | 62,20 | 65,05 | +3,80% | 4,84% | 681.435 |
| 21/03/2016 | 61,19 | 63,79 | 60,86 | 62,67 | +1,51% | 4,78% | 398.346 |
| 18/03/2016 | 60,67 | 62,16 | 59,30 | 61,74 | +1,80% | 4,72% | 804.546 |
| 17/03/2016 | 60,32 | 61,43 | 58,83 | 60,65 | -0,26% | 4,32% | 755.975 |
| 16/03/2016 | 60,82 | 61,68 | 59,30 | 60,80 | -0,29% | 3,93% | 560.088 |
| 15/03/2016 | 62,28 | 63,08 | 60,93 | 60,98 | -3,28% | 3,46% | 677.107 |
| 14/03/2016 | 63,57 | 64,15 | 62,78 | 63,05 | -0,75% | 2,16% | 443.390 |
| 11/03/2016 | 62,00 | 64,14 | 61,21 | 63,52 | +4,88% | 4,72% | 874.116 |
| 10/03/2016 | 62,50 | 63,62 | 59,83 | 60,57 | -2,32% | 6,06% | 415.017 |
| 09/03/2016 | 62,08 | 62,60 | 59,58 | 62,01 | +0,15% | 4,86% | 624.689 |
| 08/03/2016 | 63,63 | 63,94 | 61,67 | 61,92 | -2,97% | 3,57% | 546.944 |
| 07/03/2016 | 61,77 | 64,24 | 60,46 | 63,81 | +2,34% | 6,12% | 549.348 |
| 04/03/2016 | 60,82 | 63,16 | 60,22 | 62,35 | +2,45% | 4,84% | 542.936 |
| 03/03/2016 | 61,76 | 62,19 | 59,76 | 60,86 | +0,02% | 3,93% | 476.732 |
| 02/03/2016 | 59,21 | 61,20 | 59,18 | 60,85 | +2,36% | 3,41% | 743.632 |
| 01/03/2016 | 57,89 | 59,51 | 57,22 | 59,44 | +3,26% | 3,96% | 646.650 |
| 29/02/2016 | 60,84 | 61,27 | 57,17 | 57,57 | -5,14% | 6,74% | 893.993 |
| 26/02/2016 | 58,96 | 62,60 | 58,96 | 60,69 | +3,24% | 6,17% | 996.104 |
| 25/02/2016 | 58,00 | 59,20 | 57,16 | 58,78 | +2,02% | 3,51% | 558.966 |
| 24/02/2016 | 56,68 | 58,12 | 55,22 | 57,62 | +0,49% | 5,12% | 322.203 |
| 23/02/2016 | 57,53 | 58,83 | 57,24 | 57,34 | -0,99% | 2,75% | 490.839 |
| 22/02/2016 | 57,22 | 58,62 | 55,86 | 57,91 | +3,33% | 4,82% | 626.292 |
| 19/02/2016 | 55,40 | 56,11 | 54,34 | 56,04 | +0,41% | 3,19% | 1.119.696 |
| 18/02/2016 | 56,86 | 57,94 | 55,43 | 55,81 | -0,98% | 4,40% | 725.518 |
| 17/02/2016 | 55,96 | 56,88 | 55,22 | 56,37 | +1,44% | 2,98% | 805.828 |
| 16/02/2016 | 54,21 | 56,43 | 54,21 | 55,57 | +3,62% | 4,10% | 879.887 |
| 12/02/2016 | 54,14 | 54,31 | 52,74 | 53,63 | +0,21% | 2,90% | 901.207 |